APOA1 and Parkinson disease: Moreover, research by Das et al. (25) and Deng et al. (26) underscore ApoA1’s neuroprotective effects in Parkinson’s disease, while Rao et al. (27) highlight the complex interaction between ApoA1 levels and genetic factors in cognitive impairment.